Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Are Those Stocks, ABT, HEB, SKUL and TZYM, Oversold?


Print article Print article
© Marketwire 2013
2013-01-03 14:30:47 -

LONDON -- (Marketwire) -- 01/03/13 -- Wall Street Active pro-traders will be assisting investors today on ABT, HEB, SKUL and TZYM, and provide insight based on their extensive experience so that you can boost your stock portfolio on the short-term or the long-term. If you are a shareholder in any of these companies do not miss this once in a life time opportunity, as our trading experts can show how to turn $5,000 into $35,000.





Abbott Laboratories (NYSE: ABT) closed at $32.05 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in ABT by signing up to the link below.



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=970573&id=2439133&type=1& ..



Hemispherx Biopharma Inc. (NYSE MKT: HEB) closed at $0.25 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in HEB by signing up to the link below.



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=970573&id=2439136&type=1& ..



Skullcandy Inc. (NASDAQ: SKUL) closed at $6.80 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in SKUL by signing up to the link below.



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=970573&id=2439139&type=1& ..



Tranzyme Inc. (NASDAQ: TZYM) closed at $0.51 on Wednesday. Many veteran traders and analysts think this stock is oversold. Speak with our pros today about your investment in TZYM by signing up to the link below.



http://www.wallstreetactive.com/register.php : ctt.marketwire.com/?release=970573&id=2439142&type=1& ..



Disclaimer: WSA Financial is not a registered investment advisor, and nothing in this release is intended as a solicitation to buy or sell any security. Our pro-traders only aim is to educate investors based on their experience, and to share their knowhow.




Contact Person:
Ravi S. Kapur
Telecommunication, Information & Data Manager
info@wallstreetactive.com :



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com